Davita Healthcare Partners Stock News

DENVER , April 21, 2022 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss first quarter results on Thursday, May 5, 2022, at 5 p.m.

A jury in Denver, Colorado, acquitted dialysis provider DaVita and its former CEO Kent Thiry on Friday of charges that they conspired with competitors not to hire each other's employees.

LHC Group's (LHCG) latest joint venture with Archbold Medical Center to enhance home health services in Thomasville and across South Georgia.

DaVita (DVA) continues to gain traction from its strong international presence and solid DaVita Kidney Care business. However, integration risks are a woe.

DaVita (DVA) continues to gain traction from its strong international presence and solid DaVita Kidney Care business. However, integration risks are a woe.

Let's see if DaVita (DVA) stock is a good choice for value-oriented investors right now from multiple angles.

Let's see if DaVita (DVA) stock is a good choice for value-oriented investors right now from multiple angles.

RESEARCH TRIANGLE PARK, N.C. , March 1, 2022 /PRNewswire/ -- Pathalys Pharma, Inc., a private, late-stage biopharma company committed to the development and commercialization of a range of best-in-class therapies for patients with chronic kidney disease (CKD), today announced its formation made possible through initial seed financing from DaVita Venture Group, part of DaVita Inc. (NYSE: DVA ), and Catalys Pacific. Pathalys launches with a novel clinical-stage asset, upacicalcet, that was acquired through a license granted by EAPharma for exclusive rights to the development and commercialization of the product, worldwide outside of Japan and Asia . LQDA ) has been appointed CEO at Pathalys and will serve on the company''s board of directors." alt="Neal Fowler, a seasoned industry veteran and former Chief Executive Officer (CEO) at Liquidia Corporation (NASDAQ: LQDA ) has been appointed CEO at Pathalys and will serve on the company''s board of directors."> "We are excited about this opportunity to join forces with DaVita, a recognized leader in kidney care, in an effort to advance multiple best-in-class therapies for patients with CKD who are in need of better treatments – beginning with upacicalcet," said BT Slingsby, M.D., Ph.D., M.P.H., founder and Executive Chairman of Pathalys and Managing Partner, Catalys Pacific.

With market uncertainty ratcheting up, and more speculative names under pressure, now may be the time to cycle into Warren Buffett stocks. The post 7 Berkshire Hathaway Stock Picks to Buy If You Wanna

Berkshire Hathaway owned at least 10% of eight other companies' stock as of the end of 2021, according to a new filing.

DaVita (DVA) said a study suggested that dialysis patients who received Johnson & Johnson''s (JNJ) adenovirus vector-based COVID-19 vaccine were found to have similar rates of…

Berkshire Hathaway's 13F stock portfolio value increased from ~$293B to ~$331B. BRK.B's largest 3 holdings are 2/3rds of the portfolio. Read the full list here.

DaVita's (DVA) strength in dialysis patient service revenues drives its Q4 top line.

DaVita's (DVA) strength in dialysis patient service revenues drives its Q4 top line.

DVA earnings call for the period ending December 31, 2021.